| 000 | 01548 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511205710.0 | ||
| 264 | 0 | _c19910827 | |
| 008 | 199108s 0 0 eng d | ||
| 022 | _a0939-5555 | ||
| 024 | 7 |
_a10.1007/BF01729837 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYataganas, X | |
| 245 | 0 | 0 |
_aThe effect of recombinant alpha-interferon on natural killer cell activity and clinical course in patients with myelodysplastic syndrome. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cJun 1991 |
||
| 300 |
_a225-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _xanalysis |
| 650 | 0 | 4 | _aCD3 Complex |
| 650 | 0 | 4 |
_aCD4 Antigens _xanalysis |
| 650 | 0 | 4 | _aCD8 Antigens |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 |
_aLeukemia _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xanalysis |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 700 | 1 | _aEliopoulos, G | |
| 700 | 1 | _aKoulocheri, S | |
| 700 | 1 | _aViniou, N | |
| 700 | 1 | _aPlata, E | |
| 700 | 1 | _aPanagiotidis, P | |
| 700 | 1 | _aVayopoulos, G | |
| 700 | 1 | _aMeletis, J | |
| 700 | 1 | _aFessas, P | |
| 773 | 0 |
_tAnnals of hematology _gvol. 62 _gno. 6 _gp. 225-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01729837 _zAvailable from publisher's website |
| 999 |
_c1836427 _d1836427 |
||